CTI BioPharma Announces Two Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted...

Related Keywords

Chicago ,Illinois ,United States ,Texas ,American ,Prithviraj Bose ,Remy Bernarda ,Helen Ajufo ,Jenny Kobin ,American Society Of Clinical Oncology ,Nasdaq ,Memorial Sloan Kettering Cancer Center ,University Of Texas Md Anderson Cancer Center ,Biopharma Corp ,Clinical Oncology ,Annual Meeting ,Memorial Sloan Kettering Cancer ,Hematologic Malignancies ,Myelodysplastic Syndromes ,Media Contacts ,Cti Biopharma Corp ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Trade Show News ,Clinical Trials Amp Medical Discoveries ,